Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoplasmic Reticulum | 32 | 2017 | 157 | 4.790 |
Why?
|
| Calcium | 38 | 2017 | 356 | 4.420 |
Why?
|
| Myocytes, Cardiac | 20 | 2017 | 88 | 3.920 |
Why?
|
| Calcium Signaling | 15 | 2017 | 110 | 2.160 |
Why?
|
| Myocardial Contraction | 12 | 2016 | 38 | 1.860 |
Why?
|
| Myocardium | 18 | 2016 | 100 | 1.840 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 12 | 2016 | 134 | 1.530 |
Why?
|
| Heart Failure | 8 | 2010 | 141 | 1.240 |
Why?
|
| Animals | 43 | 2017 | 3311 | 1.060 |
Why?
|
| Isoproterenol | 7 | 2014 | 13 | 1.000 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 6 | 2017 | 12 | 0.890 |
Why?
|
| Heart Ventricles | 12 | 2016 | 84 | 0.870 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2013 | 58 | 0.850 |
Why?
|
| Adrenergic beta-Agonists | 4 | 2013 | 15 | 0.810 |
Why?
|
| Rabbits | 15 | 2017 | 169 | 0.750 |
Why?
|
| Calcium-Transporting ATPases | 10 | 2005 | 17 | 0.740 |
Why?
|
| Action Potentials | 4 | 2016 | 82 | 0.660 |
Why?
|
| Ion Channel Gating | 5 | 2016 | 176 | 0.640 |
Why?
|
| Heart | 5 | 2002 | 59 | 0.530 |
Why?
|
| Cells, Cultured | 12 | 2016 | 472 | 0.510 |
Why?
|
| Diastole | 7 | 2010 | 28 | 0.430 |
Why?
|
| Adrenergic Agents | 1 | 2014 | 1 | 0.430 |
Why?
|
| Nitric Oxide | 1 | 2014 | 73 | 0.420 |
Why?
|
| Receptors, Adrenergic, beta | 2 | 2017 | 7 | 0.400 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 4 | 2010 | 35 | 0.370 |
Why?
|
| Calcium Channels | 6 | 2011 | 106 | 0.360 |
Why?
|
| Calcium-Binding Proteins | 5 | 2011 | 22 | 0.360 |
Why?
|
| Mice | 9 | 2017 | 1249 | 0.350 |
Why?
|
| Models, Cardiovascular | 4 | 2016 | 14 | 0.340 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 97 | 0.330 |
Why?
|
| Ventricular Function | 3 | 2007 | 8 | 0.330 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 30 | 0.330 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2007 | 15 | 0.330 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2009 | 7 | 0.320 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2009 | 7 | 0.320 |
Why?
|
| Dantrolene | 1 | 2009 | 1 | 0.310 |
Why?
|
| Muscle Relaxants, Central | 1 | 2009 | 3 | 0.310 |
Why?
|
| Models, Biological | 5 | 2017 | 305 | 0.300 |
Why?
|
| Kinetics | 9 | 2016 | 176 | 0.290 |
Why?
|
| Cytosol | 7 | 2010 | 40 | 0.280 |
Why?
|
| Ventricular Premature Complexes | 1 | 2007 | 2 | 0.280 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 20 | 0.270 |
Why?
|
| Calsequestrin | 1 | 2007 | 30 | 0.270 |
Why?
|
| Enzyme Inhibitors | 2 | 2014 | 115 | 0.270 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 33 | 0.260 |
Why?
|
| Signal Transduction | 3 | 2017 | 402 | 0.240 |
Why?
|
| Membrane Potentials | 4 | 2016 | 167 | 0.240 |
Why?
|
| Microscopy, Confocal | 4 | 2011 | 81 | 0.220 |
Why?
|
| Sarcolemma | 2 | 1994 | 7 | 0.220 |
Why?
|
| Phosphorylation | 5 | 2014 | 131 | 0.220 |
Why?
|
| Mice, Knockout | 3 | 2014 | 283 | 0.200 |
Why?
|
| Sodium | 2 | 2016 | 56 | 0.200 |
Why?
|
| Heart Rate | 2 | 2016 | 104 | 0.190 |
Why?
|
| Rats | 10 | 2013 | 624 | 0.190 |
Why?
|
| Sulfonamides | 4 | 2011 | 44 | 0.180 |
Why?
|
| Caffeine | 4 | 2013 | 53 | 0.170 |
Why?
|
| Tetracaine | 3 | 2007 | 8 | 0.170 |
Why?
|
| Peptides | 2 | 2007 | 89 | 0.170 |
Why?
|
| Blotting, Western | 3 | 2014 | 132 | 0.150 |
Why?
|
| Microsomes | 2 | 2000 | 14 | 0.150 |
Why?
|
| Isoquinolines | 2 | 2010 | 12 | 0.150 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 337 | 0.150 |
Why?
|
| Calcium Channels, L-Type | 2 | 2009 | 50 | 0.140 |
Why?
|
| Enzyme Activation | 3 | 2014 | 111 | 0.140 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 57 | 0.130 |
Why?
|
| Nitric Oxide Synthase | 1 | 2017 | 43 | 0.130 |
Why?
|
| Chlorides | 1 | 2016 | 25 | 0.130 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 3 | 2016 | 16 | 0.130 |
Why?
|
| Magnesium | 1 | 2016 | 35 | 0.130 |
Why?
|
| Potassium | 1 | 2016 | 59 | 0.130 |
Why?
|
| Muscle Cells | 3 | 2013 | 12 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 528 | 0.120 |
Why?
|
| Sodium-Calcium Exchanger | 4 | 2001 | 9 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 364 | 0.120 |
Why?
|
| Computer Simulation | 3 | 2005 | 176 | 0.120 |
Why?
|
| Phospholipids | 1 | 1994 | 9 | 0.110 |
Why?
|
| Receptors, Endothelin | 1 | 1994 | 3 | 0.110 |
Why?
|
| Thermodynamics | 3 | 2016 | 42 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 1994 | 15 | 0.110 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2014 | 7 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 1994 | 89 | 0.110 |
Why?
|
| Benzylamines | 3 | 2011 | 10 | 0.100 |
Why?
|
| Ion Transport | 2 | 2004 | 28 | 0.100 |
Why?
|
| Nuclear Envelope | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cytoplasm | 1 | 2013 | 33 | 0.100 |
Why?
|
| Humans | 7 | 2016 | 23569 | 0.100 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2011 | 5 | 0.090 |
Why?
|
| Ion Channels | 1 | 2013 | 205 | 0.090 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 156 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 31 | 0.080 |
Why?
|
| Mice, Inbred mdx | 1 | 2009 | 1 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 62 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 104 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 6 | 1998 | 315 | 0.070 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2007 | 1 | 0.070 |
Why?
|
| Calbindin 2 | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2007 | 13 | 0.070 |
Why?
|
| Disease Progression | 1 | 2009 | 530 | 0.070 |
Why?
|
| Protein Binding | 2 | 2000 | 114 | 0.070 |
Why?
|
| Colforsin | 1 | 2007 | 12 | 0.070 |
Why?
|
| Calmodulin | 1 | 2007 | 7 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 176 | 0.070 |
Why?
|
| Research Design | 1 | 2007 | 163 | 0.060 |
Why?
|
| Electric Stimulation | 2 | 2003 | 49 | 0.060 |
Why?
|
| Homeostasis | 1 | 2005 | 65 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 69 | 0.060 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2006 | 39 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2005 | 44 | 0.060 |
Why?
|
| Biological Transport | 4 | 2013 | 38 | 0.060 |
Why?
|
| Algorithms | 2 | 2016 | 317 | 0.060 |
Why?
|
| Thapsigargin | 2 | 2000 | 4 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 87 | 0.050 |
Why?
|
| Cattle | 2 | 1994 | 112 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 148 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 186 | 0.050 |
Why?
|
| Intracellular Membranes | 2 | 2000 | 20 | 0.050 |
Why?
|
| Models, Theoretical | 2 | 2016 | 78 | 0.050 |
Why?
|
| Time Factors | 3 | 2000 | 1295 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 21 | 0.050 |
Why?
|
| Muscle Contraction | 2 | 2011 | 67 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 2 | 1998 | 10 | 0.040 |
Why?
|
| Troponin | 1 | 2000 | 10 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 1998 | 51 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 1998 | 4 | 0.040 |
Why?
|
| Calorimetry | 1 | 1997 | 4 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1997 | 5 | 0.030 |
Why?
|
| Male | 6 | 2016 | 12776 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 44 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 8 | 0.030 |
Why?
|
| Tacrolimus | 1 | 1996 | 14 | 0.030 |
Why?
|
| Cations, Monovalent | 1 | 2016 | 11 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 5 | 0.030 |
Why?
|
| Ions | 1 | 2016 | 45 | 0.030 |
Why?
|
| Rana pipiens | 2 | 2006 | 50 | 0.030 |
Why?
|
| Models, Structural | 1 | 1994 | 3 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1994 | 5 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 1994 | 6 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 21 | 0.030 |
Why?
|
| Endothelins | 1 | 1994 | 2 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 20 | 0.030 |
Why?
|
| Radioimmunoassay | 1 | 1994 | 19 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1994 | 21 | 0.030 |
Why?
|
| Membranes | 1 | 1994 | 9 | 0.030 |
Why?
|
| Liposomes | 1 | 1994 | 13 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 1994 | 10 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1994 | 22 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 12 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1994 | 57 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 1998 | 285 | 0.020 |
Why?
|
| Muscle Fatigue | 1 | 2011 | 9 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2011 | 54 | 0.020 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 3 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 9 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 8 | 0.020 |
Why?
|
| Aging | 1 | 1998 | 1101 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 104 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ruthenium Red | 2 | 2000 | 7 | 0.020 |
Why?
|
| Down-Regulation | 2 | 1998 | 91 | 0.020 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2005 | 1 | 0.020 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2005 | 2 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 22 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2005 | 20 | 0.020 |
Why?
|
| Organelles | 1 | 2005 | 4 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 32 | 0.010 |
Why?
|
| Echocardiography | 1 | 2005 | 69 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 59 | 0.010 |
Why?
|
| Allosteric Regulation | 1 | 2001 | 3 | 0.010 |
Why?
|
| Ferrets | 1 | 2001 | 4 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 11 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2000 | 7 | 0.010 |
Why?
|
| Nickel | 1 | 2001 | 20 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 13 | 0.010 |
Why?
|
| Dogs | 1 | 2001 | 148 | 0.010 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1998 | 3 | 0.010 |
Why?
|
| Ruthenium Compounds | 1 | 1998 | 2 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1998 | 11 | 0.010 |
Why?
|
| Chelating Agents | 1 | 1998 | 13 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1998 | 41 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1998 | 133 | 0.010 |
Why?
|
| Ryanodine | 1 | 1998 | 17 | 0.010 |
Why?
|
| Indoles | 1 | 1998 | 32 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1998 | 62 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 322 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1997 | 2 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1997 | 11 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 1997 | 7 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1997 | 50 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1996 | 23 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 34 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 179 | 0.010 |
Why?
|
| Female | 1 | 2007 | 13266 | 0.010 |
Why?
|
| Anti-Allergic Agents | 1 | 1950 | 2 | 0.010 |
Why?
|
| Histamine | 1 | 1950 | 7 | 0.010 |
Why?
|
| Post-Dural Puncture Headache | 1 | 1950 | 3 | 0.010 |
Why?
|
| Surgery, Plastic | 1 | 1950 | 11 | 0.010 |
Why?
|
| Headache | 1 | 1950 | 38 | 0.010 |
Why?
|
| Anesthesia | 1 | 1950 | 28 | 0.010 |
Why?
|
| Anesthesiology | 1 | 1950 | 27 | 0.010 |
Why?
|